By Chris Black
We’re getting in Dystopia fast. Remember, we are talking about a so-called new virus with a 99.9+ % survivability rate for healthy/fit people.
In search of ways to complement jabs or to treat patients who can’t be vaccinated, scientists have tested inhalable anti-Covid nanobodies on hamsters, saying they’re effective in fighting the virus by targeting its spike protein.
The promising new findings came courtesy of researchers from the University of Pittsburgh School of Medicine, marking the first time nanobodies have been tested for inhalation treatment of the coronavirus disease.
In a new paper published in @ScienceAdvances, researchers from @PittTweet showed that inhalable nanobodies targeting the spike protein of the SARS-CoV-2 coronavirus can prevent and treat severe #COVID19 in hamsters. t.co/jbsJ0H5clypic.twitter.com/PcgKjjMdEF
A formerly blind patient has unexpectedly had a portion of his visual perception restored thanks to a cutting-edge hybrid biological-technological therapy known as optogenetics..
Researchers say they have developed an “effective, low-cost therapeutic intervention” to block COVID-19 - but for now, it only works on hamsters. Nanobodies are administered directly through the nose or by inhalation, the researchers said. However, it s yet to be determined whether this treatment could work for humans.
Scientists from the University of Pittsburgh School of Medicine have demonstrated that inhalable nanobodies can prevent and cure severe COVID-19 in hamsters by targeting the spike protein of the SARS-CoV-2 coronavirus.
Fox News medical contributor Dr. Marc Siegel argues fear tactics have been used to manipulate Americans about coronavirus
Researchers from the University of Pittsburgh School of Medicine said they completed a first-of-its-kind study involving inhaled nanobodies that effectively prevented and treated severe COVID-19 in hamsters. Nanobodies are similar to monoclonal antibodies but are smaller in size, more stable and cheaper to produce, a news release explained.
For the study, which was published Wednesday in Science Advances, researchers administered low doses of the inhalable nanobody-21 (PiN-21) to hamsters to see if it protected against the dramatic weight loss associated with severe SARS-CoV-2 infection. The team said that not only did it prevent the weight loss, but it also reduced the number of infectious particles in the animals’ nasal cavities, throats and lungs by a million-fold compared to the placebo group.